Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Operations (2016 - 2025)

PAVmed has reported Cash from Operations over the past 5 years, most recently at 1506000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 1702.13% year-over-year to 1506000.0; the TTM value through Dec 2025 reached 5206000.0, up 85.75%, while the annual FY2025 figure was 5206000.0, 84.48% up from the prior year.
  • Cash from Operations for Q4 2025 was 1506000.0 at PAVmed, down from 900000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 94000.0 in Q4 2024 and troughed at 22558000.0 in Q2 2022.
  • A 5-year average of 10183631.58 and a median of 11656000.0 in 2024 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: surged 100.79% in 2024 and later crashed 1702.13% in 2025.
  • Year by year, Cash from Operations stood at 16777000.0 in 2021, then fell by 0.27% to 16823000.0 in 2022, then rose by 29.42% to 11874000.0 in 2023, then surged by 100.79% to 94000.0 in 2024, then crashed by 1702.13% to 1506000.0 in 2025.
  • Business Quant data shows Cash from Operations for PAVM at 1506000.0 in Q4 2025, 900000.0 in Q3 2025, and 1200000.0 in Q2 2025.